These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38860901)

  • 1. Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis.
    Teopiz KM; Kwan ATH; Le GH; Guo Z; Badulescu S; Ceban F; Meshkat S; Di Vincenzo JD; d'Andrea G; Cao B; Ho R; Rhee TG; Dev DA; Phan L; Subramaniapillai M; Mansur RB; Rosenblat JD; McIntyre RS
    Curr Med Res Opin; 2024 Jul; 40(7):1203-1209. PubMed ID: 38860901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine.
    Kwan ATH; Guo Z; Ceban F; Le GH; Wong S; Teopiz KM; Rhee TG; Ho R; Di Vincenzo JD; Badulescu S; Meshkat S; Cao B; Rosenblat JD; d'Andrea G; Dev DA; Phan L; Subramaniapillai M; McIntyre RS
    Adv Ther; 2024 May; 41(5):1983-1994. PubMed ID: 38520501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a
    Liao S; Teopiz KM; Kwan ATH; Le GH; Wong S; Ballum H; Rhee TG; Badulescu S; Cao B; Guo Z; Meshkat S; Phan L; Subramaniapillai M; Ho R; McIntyre RS
    Curr Med Res Opin; 2024 Aug; 40(8):1407-1411. PubMed ID: 38954402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of vortioxetine on depressive symptoms moderated by symptoms of anxiety in persons with post-COVID-19 condition: A secondary analysis.
    Le GH; Kwan ATH; Guo Z; Teopiz KM; Wong S; Meshkat S; d'Andrea G; Ho R; Rhee TG; Cao B; Badulescu S; Phan L; Rosenblat JD; Mansur RB; Subramaniapillai M; McIntyre RS
    Psychiatry Res; 2024 Sep; 339():116068. PubMed ID: 38954891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysis.
    Badulescu S; Le GH; Wong S; Kwan ATH; Guo Z; Teopiz KM; Phan L; Subramaniapillai M; Rosenblat JD; Mansur RB; McIntyre RS
    Neurol Sci; 2024 Apr; 45(4):1335-1342. PubMed ID: 38321333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial.
    McIntyre RS; Phan L; Kwan ATH; Mansur RB; Rosenblat JD; Guo Z; Le GH; Lui LMW; Teopiz KM; Ceban F; Lee Y; Bailey J; Ramachandra R; Di Vincenzo J; Badulescu S; Gill H; Drzadzewski P; Subramaniapillai M
    Brain; 2024 Mar; 147(3):849-857. PubMed ID: 37936330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium Aspartate for Long COVID Fatigue and Cognitive Dysfunction: A Randomized Clinical Trial.
    Guttuso T; Zhu J; Wilding GE
    JAMA Netw Open; 2024 Oct; 7(10):e2436874. PubMed ID: 39356507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Baseline Anxiety on Well-being in People with Post-COVID-19 Condition: A Secondary Analysis.
    Kleine N; Kwan ATH; Le GH; Guo Z; Phan L; Subramaniapillai M; McIntyre RS
    CNS Spectr; 2024 Apr; 29(2):150-154. PubMed ID: 38453677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysis.
    Le GH; Kwan ATH; Guo Z; Wong S; Badulescu S; Gill H; Teopiz KM; Meshkat S; Ceban F; Phan L; Subramaniapillai M; Di Vincenzo JD; Rosenblat JD; Mansur RB; d'Andrea G; Ho R; Rhee TG; McIntyre RS
    Acta Neuropsychiatr; 2024 Aug; 36(4):211-217. PubMed ID: 38605630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia.
    Naik H; Cooke E; Boulter T; Dyer R; Bone JN; Tsai M; Cristobal J; McKay RJ; Song X; Nacul L
    BMJ Open; 2024 May; 14(5):e085272. PubMed ID: 38740499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-COVID-19 Condition Fatigue Outcomes Among Danish Residents.
    O'Regan E; Spiliopoulos L; Bech Svalgaard I; Nielsen NM; Vedel Sørensen AI; Bager P; Videbech P; Ethelberg S; Koch A; Hviid A
    JAMA Netw Open; 2024 Oct; 7(10):e2434863. PubMed ID: 39374018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary Analysis.
    Le GH; Kwan ATH; Wong S; Guo Z; Teopiz KM; Badulescu S; Meshkat S; d'Andrea G; Ho R; Rhee TG; Cao B; Phan L; Rosenblat JD; Mansur RB; Subramaniapillai M; McIntyre RS
    Adv Ther; 2024 Feb; 41(2):686-695. PubMed ID: 38114867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition.
    Liu TC; Yoo SM; Sim MS; Motwani Y; Viswanathan N; Wenger NS
    JAMA Netw Open; 2023 May; 6(5):e2311974. PubMed ID: 37145596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Reported Experiences of Persistent Post-COVID-19 Conditions After Hospital Discharge During the Second and Third Waves of the Pandemic in Switzerland: Cross-Sectional Questionnaire Study.
    Tacchini-Jacquier N; Monnay S; Coquoz N; Bonvin E; Verloo H
    JMIR Public Health Surveill; 2024 Aug; 10():e47465. PubMed ID: 39197160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illness presentation and quality of life in myalgic encephalomyelitis/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional study.
    Weigel B; Eaton-Fitch N; Thapaliya K; Marshall-Gradisnik S
    Qual Life Res; 2024 Sep; 33(9):2489-2507. PubMed ID: 38961009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial.
    Geng LN; Bonilla H; Hedlin H; Jacobson KB; Tian L; Jagannathan P; Yang PC; Subramanian AK; Liang JW; Shen S; Deng Y; Shaw BJ; Botzheim B; Desai M; Pathak D; Jazayeri Y; Thai D; O'Donnell A; Mohaptra S; Leang Z; Reynolds GZM; Brooks EF; Bhatt AS; Shafer RW; Miglis MG; Quach T; Tiwari A; Banerjee A; Lopez RN; De Jesus M; Charnas LR; Utz PJ; Singh U
    JAMA Intern Med; 2024 Sep; 184(9):1024-1034. PubMed ID: 38848477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive Intake of a Multiple Micronutrient Supplement during Mild, Acute SARS-CoV-2 Infection to Reduce the Post-Acute COVID-19 Condition: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Tomasa-Irriguible TM; Monfà R; Miranda-Jiménez C; Morros R; Robert N; Bordejé-Laguna L; Vidal S; Torán-Monserrat P; Barriocanal AM
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater Role of Cognitive Impairment Over Fatigue in Post-COVID-19 Quality of Life: A Post-Hoc Analysis of a Randomized Controlled Trial.
    Kwan ATH; Lakhani M; Le GH; Singh G; Teopiz KM; Guo Z; Ceban F; Dhaliwal KK; Badulescu S; Ho R; Rhee TG; Cao B; d'Andrea G; McIntyre RS
    medRxiv; 2024 Mar; ():. PubMed ID: 38562760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Biopsychosocial Approach to Persistent Post-COVID-19 Fatigue and Cognitive Complaints: Results of the Prospective Multicenter NeNeSCo Study.
    Klinkhammer S; Duits AA; Deckers K; Horn J; Slooter AJC; Verwijk E; van Heugten CM; Visser-Meily JMA;
    Arch Phys Med Rehabil; 2024 May; 105(5):826-834. PubMed ID: 38228250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.